Drug Trial Radar · NCT05152914
Intravitreal ERT to Prevent Retinal Disease Progression in Children With CLN2
Last checked: Nov 20, 2026Latest source record: Apr 30, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
5
Planned (sponsor's estimate)
Start
Nov 1, 2021
Primary completion
Mar 4, 2026
Study completion Mar 6, 2027
Sponsor
- Lead sponsor
- David L Rogers, MDAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Dec 10, 2021
Design
- Study type
- Interventional
- Phase
- Phase 1 / Phase 2
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 24 months, up to 72 months
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a phase I/II randomized, masked, clinical trial to determine the safety and efficacy of intravitreal administration of cerliponase alfa.
Conditions
- Neuronal Ceroid Lipofuscinosis Type 2
Interventions
Cerliponase AlfaDrug
Brineura is a hydrolytic lysosomal N-terminal tripeptidyl peptidase indicated to slow the loss of ambulation in symptomatic pediatric patients 3 years of age and older with late infantile neuronal ceroid lipofuscinosis type 2 (CLN2), also known as tripeptidyl peptidase 1 (TPP1) deficiency.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Monitoring for the development of unacceptable toxicity.Time frame: 2 years
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Nationwide Children's Hospital
Columbus, Ohio
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.